In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Expert Advice - Focus on heart failure with preserved ejection fraction (HFpEF)
Session

Event : ESC Congress 2019

Topic : Chronic Heart Failure

  • Session type : Focus with the Experts
  • Date : 01 September 2019
  • Time : 11:00 - 12:30

4 presentations in this session

Clinical phenotype of HFpEF: the same around the world?

Event : ESC Congress 2019

  • Session : Expert Advice - Focus on heart failure with preserved ejection fraction (HFpEF)
  • Speaker : CS Lam (Singapore,SG)

Understanding the role of comorbidities in HFpEF

Event : ESC Congress 2019

  • Session : Expert Advice - Focus on heart failure with preserved ejection fraction (HFpEF)
  • Speaker : M Senni (Bergamo,IT)

Treatment of HFpEF: from failure to success

Event : ESC Congress 2019

  • Session : Expert Advice - Focus on heart failure with preserved ejection fraction (HFpEF)
  • Speaker : S Solomon (Boston,US)

Furthering our understanding of HFpEF to identify novel therapeutic targets

Event : ESC Congress 2019

  • Session : Expert Advice - Focus on heart failure with preserved ejection fraction (HFpEF)
  • Speaker : B Pieske (Berlin,DE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are